TBF Genie Tissulaire

CompanyFrance

TBF Genie Tissulaire develops one asset, in phase 2 (SclerFIX-IP in osteoarthritis hand). Mostly other acting on inflammation; based in France.

1
Asset
Furthest stage: Phase 2; 3
Trials: 0
Signals

Pipeline

1

SclerFIX-IP
Amniotic membrane interposition graft for joint cushioning and regeneration
Phase 2, Other, Inflammation, osteoarthritis hand

Full company profiles: pipeline, trials, funding and people.

In the full profile

Evidence behind the mechanisms1
Trials3
Similar companies6